Skip to main content
. 2020 Apr 1;11(6):1487–1494. doi: 10.1111/1759-7714.13415

Table 1.

Patient clinical characteristics

MISE group (n = 73) OSE group (n = 101) χ2 P‐value
Sex 0.121 0.728
Male 51 (69.9%) 73 (72.3%)
Female 22 (30.1%) 28 (27.7%)
Age 0.452 0.501
≤60 years 16 (21.9%) 18 (17.8%)
>60 years 57 (78.1%) 83 (82.2%)
ASA grade 0.440 0.803
I 30 (41.1%) 39 (38.6%)
II 34 (46.6%) 46 (45.5%)
III 9 (12.3%) 16 (15.8%)
Preoperative T stage 1.458 0.482
T1 12 (16.4%) 20 (19.8%)
T2 33 (45.2%) 51 (50.5%)
T3 28 (38.4%) 30 (29.7%)
Preoperative N stage 3.265 0.071
N0 39 (53.4%) 40 (39.6%)
N1 34 (46.6%) 61 (60.4%)
Comorbidity
Hypertension 9 (12.3%) 15 (14.9%) 0.227 0.634
Diabetes mellitus 8 (11.0%) 13 (12.9%) 0.146 0.702
COPD 8 (11.0%) 9 (8.9%) 0.202 0.653
Arrhythmia 6 (8.2%) 12 (11.9%) 0.613 0.414
Other 3 (4.1%) 5 (5.0%) 1.000 0.549

ASA, American Society of Anesthesiologists; COPD, chronic obstructive pulmonary disease; Other, brain and/or peripheral vascular lesions; MIILE, minimally invasive Ivor Lewis esophagectomy; OILE, open Ivor Lewis esophagectomy.